Pediatric Hidradenitis Suppurativa Challenge Grant
Forecasted
Pediatric Hidradenitis Suppurativa Challenge Grant supports early-to-mid career investigators pursuing patient-centric research to improve treatment and understanding of the disease in children and adolescents.
Funder: Pediatric Dermatology Research Alliance
Due Dates (Anticipated): July 2027 (Application deadline)
Funding Amounts: Up to $50,000 for one year; direct costs only; non-renewable
Summary: Supports high-priority, patient-centric research addressing hidradenitis suppurativa in children and adolescents.
Key Information: Applicants must hold an MD, PhD, or equivalent and be eligible to apply under their host institution’s guidelines.
Description
The Pediatric Dermatology Research Alliance (PeDRA), in partnership with HS Connect and the HS Foundation, offers this challenge grant to support an early-to-mid career investigator pursuing patient-centric research on pediatric hidradenitis suppurativa (HS). HS is a chronic inflammatory disease with substantial effects on quality of life, psychosocial well-being, and long-term health. It remains underdiagnosed, undertreated, and understudied in children and adolescents.
The program supports basic science, translational research, clinical research, epidemiology, and technology projects addressing treatment effectiveness, disease progression, procedures, or diverse recruitment. It prioritizes multidisciplinary collaboration involving researchers, clinicians, and patient stakeholders, as well as equity, diversity, and inclusion. Projects should help build and sustain a larger research program, with additional priority for plans to use results as the foundation for larger-scale future studies.
